Login
Explore
- Maps
- Lists
- Tags
About
- LittleSis
- Sign Up
- Help
- API
- Disclaimer
- Contact Us
- Donate
- Newsletter
Features
- Blog
- Toolkit
- Powerlines

Login
Explore
- Maps
- Lists
- Tags
About
- LittleSis
- Sign Up
- Help
- API
- Disclaimer
- Contact Us
- Donate
- Newsletter
Features
- Blog
- Toolkit
- Powerlines

donate

This year LittleSis turned 15! Consider becoming a LittleSustainer to help unsure that our movements have the research and tools
we need to win for the long haul. Any amount is greatly appreciated. Donate today.

Ludwig Hantson

CEO, Alexion Pharmaceuticals Inc.

Hantson is in his current position since 2017. Previously, he was president and CEO of Baxalta Inc. He led Baxalta's spin-off as a public company from Baxter in 2015. He joined Baxter in 2010 as president of Baxter BioScience, and previously held leadership roles with Novartis AG and Johnson & Johnson.

Relationships Interlocks Giving Data

Business Positions

Alexion Pharmaceuticals, Inc.

• CEO ('17→?)

Baxter International, Inc. Fortune 500 American health care company based in Illinois

• Corporate Vice President, President - Bioscience ('10→'15)

Board Memberships

Hologic

• Board Member ('19→?)

Updated about 4 years ago

Types	Person, Business Person
Gender	Male
Aliases	Mr Ludwig N. Hantson

Sec - Edgar

corporate-mapping-project